Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a ...

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...

KeyBanc analyst Justin Patterson raised the firm’s price target on Trade Desk (TTD) to $142 from $140 and keeps an Overweight rating on the ...

Axogen (AXGN) announced the appointment of Jesse Bishop as Vice President of Regulatory Affairs. Bishop will report to Michael Dale, President, ...

CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...

Authors Trey Grainger, Doug Turnbull, Max Irwin, release book and create online hub to inspire, educate, and showcase new breakthroughs in ...

Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines ...

The firm this month introduced its platform-independent GPU-accelerated vector indexing feature. This service is said to delivers up to 10x faster index-building times while using GPUs that rival ...

Dr. Montgomery Rice will be formally recognized at the Atlanta Business Chronicle's second annual Health Care Champion Awards ceremony on March 20, 2025.

LOGO.com has launched a new best-in-market ... reliable and precise information to our valued readers. Markets Insider and Business Insider Editorial Teams were not involved in the creation ...

Under the new management structure, the heads of Sony's major businesses will be called "Business CEOs." In Tokyo, Sony shares gained 3.78 percent on Wednesday's regular trading, to close at 3,484 ...

Revenues increased 7.9% to $108.2 million in the third quarter of 2025 from $100.3 million in the third quarter of 2024;Organic growth of 3.5% ...